Precancerous conditions of pancreatic carcinoma

2000 ◽  
Vol 7 (6) ◽  
pp. 568-574 ◽  
Author(s):  
Jutta Lüttges ◽  
Günter Klöppel
Keyword(s):  
Pancreatic Carcinoma ◽  
Precancerous Conditions

Immunotherapy of pancreatic carcinoma with siRNA targeting TGF-beta

2009 ◽  
Vol 47 (10) ◽  
Author(s):  
J Ellermeier ◽  
J Wie ◽  
P Düwell ◽  
S Endres ◽  
M Schnurr
Keyword(s):  
Pancreatic Carcinoma ◽  
Tgf Beta

Ten new primary pancreatic carcinoma cell lines

2011 ◽  
Vol 49 (08) ◽  
Author(s):  
F Rückert ◽  
D Aust ◽  
S Hering ◽  
K Werner ◽  
HD Saeger ◽  
...  
Keyword(s):  
Pancreatic Carcinoma ◽  
Cell Lines ◽  
Carcinoma Cell ◽  
Carcinoma Cell Lines

Oxytocin-producing pancreatic carcinoma presenting as ectopic ACTH syndrome

1989 ◽  
Vol 120 (3_Suppl) ◽  
pp. S17-S18
Author(s):  
W. A. SCHERBAUM ◽  
G. JIRIKOWSKI ◽  
E. F. PFEIFFER
Keyword(s):  
Pancreatic Carcinoma ◽  
Ectopic Acth Syndrome ◽  
Ectopic Acth

Pancreatic carcinoma: prognostic impact of galectin-3

2018 ◽  
Author(s):  
Fatma Khanchel ◽  
Narjess Redissi ◽  
Wafa KOUBAA ◽  
Raja Jouini
Keyword(s):  
Pancreatic Carcinoma ◽  
Prognostic Impact ◽  
Galectin 3

AZT: A Biochemical Response Modifier of Methotrexate and 5-Fluorouracil Cytotoxicity in Human Ovarian and Pancreatic Carcinoma Cells

1991 ◽  
Vol 3 (4) ◽  
pp. 127-132 ◽  
Author(s):  
George Weber ◽  
Masami Nagai ◽  
Noemi Prajda ◽  
Hiroyuki Nakamura ◽  
Thomas Szekeres ◽  
...  
Keyword(s):  
Pancreatic Carcinoma ◽  
Carcinoma Cells ◽  
Biochemical Response ◽  
Response Modifier

scholarly journals Pancreatic Carcinoma Metastatic to the Gingiva

2021 ◽  
Vol 11 (1) ◽  
pp. 58-64
Author(s):  
Arijan Zubović ◽  
Margita Belušić-Gobić ◽  
David Harmicar ◽  
Jasna Marušić ◽  
Damir Vučinić ◽  
...  
Keyword(s):  
Pancreatic Carcinoma ◽  
Pancreatic Tumor ◽  
Maxillofacial Surgery ◽  
The Body ◽  
Retroperitoneal Mass ◽  
Immunohistochemical Examination ◽  
Normal Result ◽  
Highly Sensitive ◽  
Gingival Neoplasm ◽  
Malignant Lesions

Metastatic tumors to the oral cavity are uncommon, representing approximately 1% of all cases of oral malignant lesions even when a metastatic disease is present. The 53-year-old female is presented complaining of abdominal pain, weight loss, and a loose stool recurring not more than three times per day. A computed tomography (CT) scan of the abdomen showed a retroperitoneal mass expanding along the body of the pancreas. Colonoscopy and gastroscopy with a gastric mucosa biopsy showed a normal result. After laparoscopic surgery, the primary site of adenocarcinoma was not confirmed. The patient was referred to the Maxillofacial Surgery Clinic with pain, swelling, and occasional bleeding around the lower right second mollar. Immunohistochemicaly, the tumor cells were positive for Cytokeratin (CK) 19, Cytokeratin (CK) 7, and homebox protein (CDX-2), which are highly sensitive markers of pancreatobiliar cancer. Therefore, the patient was diagnosed with pancreatic carcinoma. This report describes a rare metastasis of malignant pancreatic tumor to the lower right gingiva and highlights the importance of immunohistochemical examination and how it helped identify both the origin and the nature of gingival neoplasm.

Integrin-Mediated Differentiation of a Pancreatic Carcinoma Cell Line Is Independent of FAK or MAPK Activation Levels

Pancreas ◽  
2001 ◽  
Vol 23 (3) ◽  
pp. 236-245 ◽  
Author(s):  
Volker Stagge ◽  
Thomas Seufferlein ◽  
Daniel Dürschmied ◽  
Andre Menke ◽  
Guido Adler ◽  
...  
Keyword(s):  
Pancreatic Carcinoma ◽  
Cell Line ◽  
Carcinoma Cell ◽  
Carcinoma Cell Line ◽  
Mapk Activation ◽  
Pancreatic Carcinoma Cell Line

Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma

2000 ◽  
Vol 11 (8) ◽  
pp. 635-638 ◽  
Author(s):  
Helmut Oettle ◽  
Dirk Arnold ◽  
Martin Esser ◽  
Dieter Huhn ◽  
Hanno Riess
Keyword(s):  
Pancreatic Carcinoma ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Advanced Pancreatic Carcinoma
Sign in / Sign up

Export Citation Format

Share Document